Results 81 to 90 of about 719,957 (193)

Case Report: Pulmonary mucormycosis caused by Rhizopus microsporus in a patient with chronic obstructive pulmonary disease

open access: yesFrontiers in Medicine
BackgroundWe report a rare case of pulmonary mucormycosis caused by Rhizopus microsporus, which is rare in patients with chronic obstructive pulmonary disease.
Shanshan Wang   +4 more
doaj   +1 more source

The Role of Invasive Procedures in the Treatment of Complicated Gastrointestinal Graft‐Versus‐Host Disease in Pediatric Patients

open access: yesPediatric Blood &Cancer, Volume 73, Issue 7, July 2026.
ABSTRACT Background Gastrointestinal graft‐versus‐host disease (GI GVHD) following hematopoietic stem cell transplant is typically managed with medical therapy, but surgery and angioembolization may be warranted in selected cases with life‐threatening complications.
Gaia Brunetti   +12 more
wiley   +1 more source

Pulmonary Mucormycosis With Cavitatory Lung Involvement: A Fatal Case Despite Combined Therapy

open access: yes
Background Mucormycosis is a rare, life-threatening fungal infection. Pulmonary mucormycosis is primarily presented in patients with haematological malignancies and solid organ transplants.
Kehelovitagamage Oshadee Vasundara Kehelovitagama   +7 more
core   +1 more source

An Update on Invasive Fungal Infections in Solid Organ Transplant Recipients

open access: yesTransplant Infectious Disease, Volume 28, Issue 4, July/August 2026.
ABSTRACT Invasive fungal infections (IFI) remain a significant infection‐related complication in solid organ transplant recipients (SOTRs), the incidence of which has not changed overtime. With a focus on studies and data published after 2019, this narrative review provides an update on the epidemiology and prevention of IFIs in SOTRs and highlights ...
Tina Marinelli, Shahid Husain
wiley   +1 more source

Cutaneous Mucormycosis Clinically Mimicking Necrotizing Fasciitis in a Patient Without Active Immunosuppression

open access: yesClinical Case Reports, Volume 14, Issue 6, June 2026.
ABSTRACT Cutaneous mucormycosis is a rare invasive fungal infection caused by fungi of the order Mucorales. Although it classically occurs in immunocompromised hosts, traumatic or minor cutaneous inoculation may result in infection even in patients without active immunosuppression.
Akın Öğünç İnan   +5 more
wiley   +1 more source

Pulmonary Mucormycosis

open access: yesNew England Journal of Medicine, 2021
Leonardo, Mejia Buritica   +1 more
openaire   +3 more sources

Purpuric targetoid eruption revealing disseminated mucormycosis

open access: yes
Journal of the European Academy of Dermatology and Venereology, Volume 40, Issue 9, Page 1550-1551, September 2026.
Francisco Mano, João Teixeira
wiley   +1 more source

Pulmonary Mucormycosis in a Hematology Ward.

open access: yesInternal Medicine, 1996
During a 24-year period, seven patients with leukemia undergoing cytotoxic or immunosuppressive therapy developed pulmonary mucormycosis in our hematology ward. The autopsy incidence in patients with acute leukemia was 2.1%, with no significant rise during the last decade. Most cases occurred in early autumn.
FUNADA, Hisashi, MATSUDA, Tamotsu
openaire   +3 more sources

Pulmonary Mucormycosis – An Experience from a Tertiary Care Center in Southern India: A PULM MUCOR Study

open access: yesCurrent Medical Issues
Background: Pulmonary mucormycosis is a rare life-threatening fungal infection that primarily affects immunocompromised individuals, leading to severe morbidity and high mortality.
Ashwin Oliver Arul   +2 more
doaj   +1 more source

Is universal CAR T‐cell referral absolutely required for transplant‐ineligible patients with primary refractory or early relapsed DLBCL?

open access: yes
British Journal of Haematology, Volume 209, Issue 1, Page 349-352, July 2026.
Maria Dimou   +1 more
wiley   +1 more source

Home - About - Disclaimer - Privacy